Investigation Overview
September 23, 2013 (Shareholders Foundation) - An investigation on behalf of investors in shares of Transcept Pharmaceuticals Inc (NASDAQ:TSPT) was announced concerning whether certain Transcept Pharmaceuticals officers and directors possibly breached their fiduciary duties in connection with the newly adopted tax benefit preservation plan. The investigation by a law firm concerns, a...
You must register (for free) or login to view the entire investigation.